Cytowanie według stylu APA (wyd. 7)

Halioua-Haubold, C., Jolly, J., Smith, J., Villanueva, R., Brindley, D., & MacLaren, R. (2019). Potential lifetime quality of life benefits of choroideremia gene therapy: Projections from a clinically informed decision model. Springer Nature.

Cytowanie według stylu Chicago (wyd. 17)

Halioua-Haubold, C-L, JK Jolly, JA Smith, R. Villanueva, DA Brindley, i RE MacLaren. Potential Lifetime Quality of Life Benefits of Choroideremia Gene Therapy: Projections from a Clinically Informed Decision Model. Springer Nature, 2019.

Cytowanie według stylu MLA (wyd. 9)

Halioua-Haubold, C-L, et al. Potential Lifetime Quality of Life Benefits of Choroideremia Gene Therapy: Projections from a Clinically Informed Decision Model. Springer Nature, 2019.